hTS/Ink4a/Arf−/− mice developed large STS such as liposarcoma (LS), rhabdomyosarcomas (RMS) and leiomyosarcoma (LMS) that ranged from 1.5 g to 10.1 g. This evidence concerns the gene CDKN2A and leiomyosarcoma.